METTL3 and acute myeloid leukemia: Recently, Yankova et al. identified a highly potent and selective first-in-class catalytic inhibitor of METTL3, STM2457, which reduces acute myeloid leukemia growth and increases differentiation and apoptosis by selectively reducing m6A levels on known leukemogenic mRNAs 49.